Spiro George Rombotis's Net Worth

-$69.5 Thousand

Estimate Recalculated Sep 8, 2024 07:34PM EST

Who is Spiro George Rombotis?

Spiro George Rombotis does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Cyclacel Pharmaceuticals, Inc..

SEC CIK

Spiro George Rombotis's CIK is 0001357396

Past Insider Trading and Trends

2008 was Spiro George Rombotis's most active year for acquiring shares with 19 total transactions. Spiro George Rombotis's most active month to acquire stocks was the month of November. 2008 was Spiro George Rombotis's most active year for disposing of shares, totalling 2 transactions. Spiro George Rombotis's most active month to dispose stocks was the month of October. 2006 saw Spiro George Rombotis paying a total of $640,430.60 for 614,282 shares, this is the most they've acquired in one year. In 2010 Spiro George Rombotis cashed out on 83,350 shares for a total of $20,875.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $1.02

President and CEO

Spiro George Rombotis owns 479,648 units of Common Stock, par value $0.001 per share which is worth $489,240.96, 68,658 units of Common Stock which is worth $70,031.16, 241,416 units of Common Stock, $0.001 par value per share which is worth $246,244.32, 400 units of Preferred Stock, $0.001 par value per share which is worth $408.00 and 1,600 units of Preferred Convertible Exchangeable Stock 6% which is worth $1,632.00. From 2006 to 2023 Spiro George Rombotis acquired a total of 1,083,343 shares in Cyclacel Pharmaceuticals, Inc. at a cost of $906,834.24, Spiro also disposed a total of 27,350 shares of Cyclacel Pharmaceuticals, Inc. equalling to $29,797.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.70%
6.07K
$3.32
$20,122.05
68.66K
Dec 21
Form 4
—
0
—
—
0
Jun 30
Form 4
+1,154.77%
57.6K
—
—
62.59K
Jan 31
Form 4/A
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Dec 13
Form 4
+404.86%
4K
$4.50
$18,000.00
4.99K
Nov 18
Form 4
—
0
—
—
0
Dec 11
Form 4
—
0
—
—
0
Dec 5
Form 4
—
0
—
—
0
Jan 3 - Jan 4
Form 4
—
0
—
—
0
Dec 7
Form 4
—
0
—
—
0
Feb 18
Form 4
—
0
—
—
0
Dec 9
Form 4
+70.71%
100K
$3.00
$300,000.00
241.42K
May 21
Form 4
+59.42%
100K
$3.00
$300,000.00
268.29K
May 21
Form 4
+10.44%
30.79K
—
—
325.79K
Jan 25
Form 4
+6.56%
90.9K
$0.47
$40,871.49
1.48M
Dec 22 - Dec 23
Form 4
+12.92%
75K
—
—
655.61K
Dec 6
Form 4
+5.23%
30.3K
$1.79
$18,805.10
610.13K
Sep 22 - Sep 23
Form 4
+2.19%
12.4K
$1.95
$9,342.80
579.83K
Sep 13
Form 4
+1.65%
9.23K
$0.73
$6,720.90
567.43K
Aug 22
Form 4
—
0
—
—
0
Dec 10
Form 4
+15.52%
75K
$0.44
$33,000.00
558.2K
Jun 9
Form 4
-1.70%
-8.35K
$2.50
-$20,875.00
483.2K
Scheduled
Apr 23
Form 4/A
+11.64%
50K
—
—
479.65K
Nov 18
Form 4
+0.68%
3K
$0.37
$1,110.00
441.55K
Dec 2
Form 4
+2.07%
8.9K
$0.35
$3,119.90
438.55K
Nov 19 - Nov 20
Form 4
—
0
—
—
0
Nov 18
Form 4/A
+4.63%
19K
$0.47
$8,922.00
429.65K
Nov 17 - Nov 18
Form 4
-4.58%
-19.00K
$0.47
-$8,922.00
429.65K
Nov 17 - Nov 18
Form 4
+2.24%
9K
$1.71
$15,395.00
410.65K
Aug 18 - Aug 19
Form 4
+2.55%
10K
$2.03
$20,270.00
401.65K
Jun 4 - Jun 5
Form 4
+1.64%
12.5K
$2.33
$28,990.00
776.3K
May 20 - May 21
Form 4
+4.11%
15K
$2.59
$38,780.00
379.65K
May 14 - May 15
Form 4
+0.80%
5.8K
$2.75
$15,950.00
726.7K
Mar 19 - Mar 20
Form 4
+0.67%
2.4K
$5.48
$13,142.00
358.85K
Dec 19 - Dec 20
Form 4
—
0
—
—
0
Dec 6
Form 4
—
0
—
—
0
Dec 21
Form 4
+0.39%
1.4K
$5.60
$7,838.00
356.45K
Sep 14 - Sep 15
Form 4
+0.03%
100
$5.95
$595.00
355.05K
Sep 12
Form 4
+0.11%
400
$5.72
$2,287.00
354.95K
Sep 8 - Sep 11
Form 4
+0.17%
600
$4.67
$2,799.00
354.55K
Sep 6 - Sep 7
Form 4
—
0
—
—
0
Jun 14
Form 4
+0.03%
100
$7.74
$774.00
353.95K
Apr 17
Form 4
∞
353.85K
—
—
353.85K
Mar 27
Form 3
—
0
—
—
0
No matching records found